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w-3 fatty acids attenuate glomerular capillary hydraulic pressure in
rats with renal ablation. To clarify the emerging role of w-3 fatty acids
(FA5) in the regulation of the renal microcirculation, we recently per-
formed micropuncture studies in normal rats maintained on diets enriched
with w-3 FAs. Although those studies suggested that w-3 FAs alter the
renal microcirculation in normal rats, it was not apparent whether this
dietary maneuver could modulate intrarenal hemodynamics in the setting
of renal disease. Therefore, the present renal micropuncture studies were
performed in nephrectomized rats maintained on control diets or diets
enriched with w-3 FAs. w-3 FAs abrogated glomerular capillary (56.2
0.8 vs. 63.9 2.0mm Hg) and transcapillary hydraulic pressure (40.9 1.4
vs. 50.6 1.3 mm Hg) compared to untreated rats. This effect was
attributable to (1) a reduction in mean arterial pressure (138 3 vs. 163
2 mm Hg) and (2) a decrease in efferent arteriolar resistance (0.43
0.06 vs. 0.98 0.19 dyn X seconds X cm5 X 1010). Sclerosis index and
albuminuria were also lessened by this dietary maneuver. To further
characterize the mechanism of altered renal arteriolar resistance, we then
explored the effects of w-3 FAs on renal prostaglandin synthesis and
angiotensin IT-stimulated phospholipid turnover. A significant decrease in
the urinary excretion of the renal vasoconstrictor, TXA2 (12.8 2.3 vs.
35.1 14.0 ng/24 hr), was induced by treatment with o-3 FAs. Moreover,
angiotensin TI-stimulated phospholipid turnover was attenuated in intact
glomeruli pretreated with w-3 FAs. We conclude that w-3 FAs exert
favorable effects on experimental renal injury by eliciting a salutary effect
on the renal microcirculation of rats subjected to subtotal renal ablation.
Moreover, the similarities between these findings and those obtained with
sustained inhibition of angiotensin II converting-enzyme suggest that
these compounds act through parallel pathways of inhibition.
Although w-3 fatty acids are well established as essential
nutrients in developing humans and adults [1], their status as
therapeutic agents in the management of various clinical condi-
tions has only recently received attention [2, 3]. In spite of early
enthusiasm for utilizing these agents in the management of
progressive renal disease [3], hypertension [4], and atherosclerosis
[5] a consensus regarding the role of w-3 fatty acid supplementa-
tion in these conditions has yet to be established. Essential to
proposing a utility for these agents in the management of disor-
ders of the microcirculation, such as progressive renal disease, is
an appreciation of the physiological implications of such manip-
ulation. Importantly, recent studies from our laboratory have
demonstrated that dietary consumption of w-3 fatty acids can
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modulate the renal microcirculation in a pattern which parallels
that observed after sustained inhibition of angiotensin II convert-
ing-enzyme. Specifically, increases in single nephron glomerular
filtration rate (SNGFR) and single nephron plasma flow (QA)
were observed in normal rats fed diets enriched with menhaden
oil [6]. A reduction in total renal arteriolar resistance and, in
particular, efferent arteriolar resistance was responsible for in-
creased QA and SNGFR in this model. While several studies have
suggested that w-3 fatty acids can modulate intrarenal hemody-
namics in experimental renal injury, those studies have failed to
specifically examine glomerular hemodynamics following dietary
enrichment with w-3 fatty acids. Therefore, the purpose of the
present study was to test the hypothesis that o-3 fatty acids
abrogate abnormal glomerular hemodynamics in the setting of
renal disease. Accordingly, we chose to study the effects of w-3
fatty acids in rats subjected to subtotal renal ablation, since this
model is characterized by sustained glomerular capillary hyper-
tension which can be abrogated by selective inhibition of angio-
tensin II [7, 8]. The studies reported herein demonstrate that
administration of w-3 fatty acid enriched diets lessened glomeru-
lar capillary hydraulic pressure (PGC) and reduced renal arteriolar
resistance in remnant nephrons. We then sought to determine the
potential mechanisms which may contribute to these hemody-
namic adjustments. Decreased intrarenal liberation of the potent
renal vasoconstrictor TXA2 and/or attenuation of angiotensin
IT-stimulated phospholipid turnover may each contribute to the
hemodynamic effects of w-3 fatty acids. An additional objective of
these investigations was to assess the effects of w-3 fatty acids on
progressive renal injury, since previous investigations have sug-
gested that diets enriched with w-3 fatty acids may either retard or
accelerate the rate of progressive glomerular injury following
renal ablation [9—.12]. Thus, long-term investigations of glomeru-
lar morphology and albuminuria were also carried out.
Methods
Experimental design
Study 1. An initial investigation was performed to characterize
the effects of diets enriched with o-3 fatty acids on glomerular
hemodynamics in rats with renal ablation. In these studies 20 male
Sprague-Dawley rats were subjected to subtotal renal ablation and
randomly assigned to standard laboratory chow (N = 10) or chow
enriched with 17% menhaden oil (N = 10) (ICN Biochemicals,
Costa Mesa, CA, USA). Rats (N = 10) subjected to sham surgery
served as controls. The diets were virtually isocaloric (4.45 vs. 4.63
Kcal/g diet in the control and menhaden oil enriched diet,
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respectively) and provided equivalent protein concentrations
(20.8%). Linoleic acid (4.5% corn oil) was provided in sufficient
quantities in each dietary group to prevent essential fatty acid
deficiency. In addition, Tenox 20 (butylated hydroxytoluene;
Eastman Kodak, Rochester, NY, USA), and a-tocopherol
(0.33%) was present in each diet to inhibit autooxidation. Rats
were pair-fed for a period of four to six weeks and then prepared
for glomerular micropuncture studies as described below. More-
over, systemic tail-cuff blood pressure measurements were ob-
tained at this time interval.
Study 2. Since the effects of w-3 fatty acids on the renal
microcirculation paralleled those observed following the admin-
istration of angiotensin II converting-enzyme inhibition we then
wished to explore the effects of w-3 fatty acids on angiotensin
Il-stimulated phosphatidylinositol hydrolysis, since hydrolysis of
phosphatidylinositol with subsequent liberation of lipid second
messengers is thought to modulate cell contraction and hence
vascular resistance in the glomerulus [13, 14]. Six-week-old male
Sprague-Dawley rats were fed standard laboratory chow or chow
supplemented with 17% menhaden oil. Intact glomeruli were
isolated after four to six weeks of dietary supplementation.
Following a 45 minute stabilization period, glomerular suspen-
sions were stimulated with I X 10_s M angiotensin II. The
incubations were terminated with iced methanol at early time
intervals (< 2 mm) and mass quantities of sn-1,2-diacylglycerol
(sn-1,2-DAG) determined. Early intervals were chosen to reflect
principally phosphatidylinositol hydrolysis rather than phosphati-
dylcholine degradation [15, 16]. In a separate group of rats lipid
was extracted from glomeruli and analyzed for fatty acid compo-
sition.
Study 3. Since glomerular capillary hypertension is thought to
evoke adverse structural changes in remnant glomeruli, we also
wanted to examine the effects of w-3 fatty acids on progressive
glomerular destruction. Therefore, a long term investigation (10
weeks) to characterize the extent of glomerular injury in nephrec-
tomized rats maintained on w-3 fatty acids was carried out. The
experimental groups and diets were identical to those described in
study 1. Twenty-four hour urine collections for albumin excretion
were obtained at three, six and nine weeks following subtotal renal
ablation. In addition, glomerular morphometry was performed at
the termination of the study. In order to confirm the authenticity
of the diet administered and the potential interrelationship of
lipid composition, renal injury, and prostaglandin turnover we
also performed fatty acid analysis of the renal cortex at the
termination of these studies. Blood was obtained at the termina-
tion of the experiment for serum albumin, total protein, choles-
terol, triglycerides, urea nitrogen, and creatinine determinations.
In addition, since w-3 fatty acids have been shown to modulate
dienoic prostaglandin metabolism we obtained 24 urine collec-
tions for prostaglandin metabolites at three, six, and nine weeks
post-renal ablation.
Preparation of nephrectomized rats
Surgical reduction of renal mass was carried out as previously
described [17]. Briefly, rats were anesthetized with an intraperi-
toneal injection of sodium pentobarbital (Nembutal®). Under
anesthesia, the left kidney was exposed with blunt dissection, and
2/3 infarcted by ligating branches of the renal artery. The right
kidney was tied off and removed. After a thorough check for
bleeding, the subcutaneous tissue was closed followed by a
blind-stitch to the inner layer of the skin.
Micropuncture techniques
Rats were anesthetized with sodium pentobarbital (50 mg/kg
body wt), placed on a temperature controlled operating table, and
prepared for micropuricture as previously described [18]. Briefly,
a tracheotomy was performed, the left femoral vein was cannu-
lated (PE-50) and a bolus of Ringer's solution (0.5% body wt) was
slowly administered over 15 minutes. Ringer's solution containing
25 jsCi 3H-inulin/ml was then infused at a rate of 0.5 ml/hr/100 g
body wt for the remainder of the experiment. The femoral artery
was cannulated (PE-50) and mean arterial pressure was moni-
tored with a digital display pressure transducer. A bladder cath-
eter (PE-50) was placed suprapubically. The left kidney was
exposed by a subcostal incision, dissected free of perinephric
tissue, immobilized in a plastic holder, and continuously bathed in
mineral oil at 37.5°C. After a 45-minute stabilization period, urine
was collected in preweighed tubes for 30 minutes. During this
interval, three to four timed (3 to 4 mm) proximal tubular fluid
collections were obtained from randomly selected superficial
nephrons to determine SNGFR. Samples of urine, plasma, and
tubular fluid were added to scintillation cocktail, and radioactivity
of the samples measured in a liquid scintillation spectrometer
(Model LS 230; Beckman Instruments, Inc., Fullerton, CA, USA).
Intratubular hydraulic pressures were measured under free-
flow conditions in one group of tubules. Proximal tubular stop-
flow pressures were obtained in the first surface convolutions
distal to Bowman's space, after blockage of the tubular lumens
with Sudan Black mineral oil. Pressures were also determined in
randomly selected efferent vascular welling points. All pressure
measurements were performed with a servo-null micropressure
system (W-P Instruments, Inc., New Haven, CT, USA). GC was
calculated as the sum of the proximal tubular stop-flow pressure
and arterial colloid osmotic pressure (COP). Plasma COP was
determined directly utilizing a cotloid osmometer (Model 4401,
Wescor, Inc., Logan, UT, USA). Blood samples were taken from
efferent vascular welling points and analyzed, together with an
arterial sample, for afferent (CA) and efferent (CE) arteriolar
protein concentration using the Micro-Lowry technique. Single
nephron filtration fraction (SNFF) and °A were calculated as
follows:
CA SNGFRSNFF—1-- °A
CE SNFF
The glomerular ultrafiltration coefficient (l(f) was calculated using
an iterative method as previously described [16]. Renal afferent
(RA) and efferent (RE) arteriolar resistance were calculated using
the following relationships:
RA = 7.692 X 1010 X (MAP—Pc) x (1—Hct) QA
RE = 7.692 X 10 x (PGC — E)
(/QA\
I — Hct)
—
SNGFR)
P is efferent arteriolar pressure.
Tissue fatty acid determinations
The fatty acid composition of renal cortical tissue was deter-
mined as previously described [19]. Briefly, one-half gram of fresh
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or frozen tissue was placed in 5 ml of preheated (90 to 95°C)
dilute (0.02 N) acetic acid and heated for 30 minutes, homoge-
nized, and then centrifuged at 12,000 rpm for 15 minutes at 0°C.
The pellet was washed with 5 ml of dilute acetic acid. The lipid
was extracted from the pellet by rehomogenizing in chloroform!
methanol (1:1, vol!vol) and centrifuging at 3,000 rpm for five
minutes. The pellet was re-extracted with chloroform!methanol
(1:1, vol!vol) and centrifuged. The pellet was then re-extracted a
final time with chloroform,'methanol (1:2) and the combined
chloroform extracts were evaporated to dryness and the lipid
dissolved in a known volume of chloroform. The methyl esters of
the phospholipid and triacyiglycerol fractions were transesterified
using hexane.
The fatty acid methyl esters were analyzed on a Varian Model
3500 capillary gas chromatograph equipped with a flame ioniza-
tion detector and a 30 meter capillary column (Supelcowax 10,
Supelco, Inc., Bellefonte, PA, USA). The column temperature
was programmed from 200°C to 225°C at 1.5°C/mm increments
with a final hold of 17 minutes. Fatty acid standards were obtained
from Supelcowax (PUFA 1, PUFA 2, Supelco Inc., Bellefonte,
PA, USA).
Glomerular morphometty
Renal tissue from rats was examined in a blinded manner using
light microscopy (400 X). Coronal sections were fixed in Zenker's
solution, embedded in paraffin, and stained with periodic acid-
Schiff (PAS) and Masson's trichrome stain.
Sclerosis index was determined based upon the method of Raij
[20]. One hundred glomerular profiles were examined and as-
signed a semiquantitative score as follows: 0 is no sclerosis, I is
25% of the profile involved, 2 is > 25% but 50% of the profile
involved, 3 is > 50% but 75% of the profile involved, and 4 is
> 75% of the profile involved.
Glomerular areas were measured using a point counting
method [21]. For each tissue specimen, 25 glomeruli encountered
on a serpentine course between cortex and medulla were evalu-
ated with a 100 point, calibrated, grid. The area of each glomer-
ular cross-section was determined by multiplying the fraction of
the points from the 100 point grid falling on the glomerular tuft by
the area associated with each point. The glomerular area for each
specimen was calculated as the mean of 25 individual measure-
ments.
Mean glomerular volumes were determined by measuring the
volume of at least 15 glomeruli using the Cavalieri principle [22].
The area was defined as the minimal convex polygon surrounding
the capillary tuft estimated by superimposing a calibrated grid and
counting the points falling on each profile. Only completely
sectioned glomeruli were included in the analysis.
Prostaglandin determinations
Specific antibody to PGE2 and TXB2 (stable metabolite of
TXA2) was utilized to determine prostaglandin concentrations in
urine. The antisera for these studies (Cayman Biologicals, Ann
Arbor, MI, USA) has < 0.02% cross reactivity with other dienoic
prostanoid metabolites. The enzyme immunoassay (ETA) system
employed for these studies has excellent correlation (r2 = 0.99)
with gas chromatography!mass-spectrometry as previously de-
scribed [23].
Urine aliquots (3 ml) were acidified to pH 3 to 3.5 with 0.1 N
HCI acid and then passed through an octadecylsilica C18 column
which had been activated with 10 ml methanol and washed with 10
ml water. The sample was then eluted with 10 ml of water,
followed by 10 ml n-hexane and 10 ml ethylacetate. The ethylac-
etate fraction was taken to dryness under nitrogen, reconstituted
with 0.5 ml ETA buffer and then subjected to EIA. Individual
measurements of PGE2 and TXB2 were corrected for percent
recoverability by adding a known quantity of 3H-PGE2 or 3H-
TXB2 to the urine samples. Recovery ranged from 50 to 70%.
Urinary albumin excretion and serum chemistries
Twenty-four-hour urine collections were made with rats indi-
vidually housed in metabolic cages. The urinary albumin concen-
tration was determined utilizing an enzyme-linked immunoasssay
system. (Exocell, Inc., Philadelphia, PA, USA).
Serum chemistries were performed colorimetrically using an
autoanalyzer (Multistat III +, Instrumentation Laboratories, Lex-
ington, MA, USA) as previously described [17].
Preparation of intact glomeruli
Following pentobarbital anesthesia the kidneys were perfused
with 200 to 300 cc phosphate buffered saline (PBS) and then
immediately removed and placed on ice. The renal cortex was
trimmed, minced, and then passed through a series of steel mesh
sieves of progressively smaller diameter (75, 150, 200 mesh).
Glomeruli were then collected in Krebbs Henselheit (KH) and
centrifuged at 3000 rpm x 30 minutes followed by resuspension in
KH. The washing procedure was performed twice. Glomeruli
were then treated with collagenase (type II, Sigma Chemical Co.,
St. Louis, MO, USA) and 0.03% DNase with gentle agitation (140
cycles/mm) for 30 minutes to disrupt Bowman's capsule. After
treatment the glomeruli were washed twice in KH and then
resuspended in warm KH. Glomeruli were examined by light
microscopy and deemed suitable for subsequent studies if> 90%
purity was validated. After basal measurements of sn-1,2-DAG
were obtained, angiotensin 11(1 x 10—8 M) was administered and
the reaction terminated at timed intervals (15 seconds, 30 sec-
onds, 1 mm, and 2 mm) with iced methanol.
sn-1,2-DAG quantitation
Mass amounts of sn-1,2-DAG were quantitated using a modi-
fication of the assay developed by Priess et al (241. Briefly, the
sn-1,2-DAG's were extracted into chloroform and then converted
to 32P-phosphatidic acid utilizing E. co/i sn-1,2-DAG kinase and
32PATP of known specific activity. The amount of sn-1,2-DAG
present in the sample was calculated from the amount of 32P-
phosphatidic acid generated.
Since E. co/i sn-1,2-DAG kinase is stereospecific for sn-1,2-
DAG, sn-1,2-DAG was quantitated as soon as possible after
extraction to minimize acyl migration. The presence of sn-1,3-
DAG and other nonreactive isomers was determined by thin layer
chromatography. sn-1,2-DAG for use in generating a standard
curve was prepared by digestion of 1,2-dioleoyl-sn-glycero-3PtdCh
with phospholipase C from Bacillus cereus. The dioleoylglycerol
generated from this hydrolysis was isolated by preparative silica
gel G thin layer chromatography. The amount of standard sn-1,2-
DAG was assayed by ester hydrolysis according to Stern and
Shapiro [25].
Statistics
Data are expressed as the mean the SEM. All variables were
screened using indices of kurtosis and skewness to determine
whether the distribution was approximately Gaussian. When the
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Table 1. Summary of renal microcirculation studies
Groups
Body wt
g
Left Kidney
wt
g Hct
MAP
mm Hg
GFR
cc/mm
Poc 'T
mm Hg
co-3 FAs 358 13 1.42 01bc 49 1 138 3" 0.59 0.071m 56.2 0.8c 15.2 0.6 40.9 1.4c
(N =
SRA
8) 341 16 1.61 0.11 47 1 163 2h 0.54 005b 63.9 2.0l 13.4 0.7 50.6 1•3b
(N =
Control
8) 347 10 1.11 0.1 48 1 108 4 2.16 0.14 52.6 1.6 13.7 1.1 38.9 1.5
(N = 6)
Abbreviations are: FAs, fatty acids; SRA, subtotal renal ablation; Body wt, body weight; Left kidney wt, left kidney weight; Hct, hematocrit; MAP,
mean arterial pressure; GFR, glomerular filtration rate; P0 glomerular capillary pressure; P, transcapillary pressure; QA' single nephron plasma flow;
SNGFR, single nephron glomerular filtration rate; RA, afferent arteriolar resistance; RE efl'erent arteriolar resistance; Kf, ultrafiltration coefficient.
a Left kidney GFR for SRA rats versus 2-kidney GFR for controls
b p < 0.05 vs. control
P< 0.05 vs. SRA
Table 1. Continued
Groups
QA SNGFR RA X 1010 RE X 1010 K
ni s mm Hgni/mm s cm5
(0-3 FAs 414 51be 113 14b 0.85 008b 0.43 006bc 0.085 0019b
(N =
SRA
8)
294 45" 96 14" 1.65 0.32 0.98 0.19" 0.045 0.006
(N = 8)
Control 110 7.5 32 2 2.20 0.37 1.54 0.15 0.030 0.000
(N = 6)
mean of two groups was compared the Student's t-test was
employed. When the mean of three groups was compared
ANOVA was employed, followed by the Bonferroni-Dunn multi-
ple comparison procedure. All statistical analyses were performed
on a Macintosh computer using the SYSTAT statistical software
package (SYSTAT, Evanston, IL, USA).
Results
Study 1
The administration of w-3 fatty acid enriched diets to rats with
renal ablation had several salutary effects on the renal microcir-
culation, as summarized in Table 1. Most striking was the
attenuation of glomerular and transcapillary hydraulic pressure.
Although, subtotal renal ablation evoked the expected adaptive
increase in GC, w-3 fatty acid supplemented diets restored GC to
control values. w-3 fatty acid enriched diets also restored trans-
capillary hydraulic pressure in rats with subtotal renal ablation.
The mechanism responsible for ameliorating the adaptive in-
crease in glomerular capillary pressure in this model was attrib-
utable to two factors. First, rats receiving diets enriched with w-3
fatty acids demonstrated a 15% reduction in mean arterial
pressure as compared to untreated nephrectomized rats. These
effects were evident at the time of micropuncture and also in
awake rats using the tail-cuff method (178 11.4 vs. 148 12.6
mm Hg). Second, w-3 fatty acid administration significantly
diminished efferent arteriolar resistance in nephrectomized rats.
Although afferent arteriolar resistance was correspondingly re-
duced by w-3 fatty acid enriched diets these trends did not achieve
statistical significance (P < 0.07). The former effect is particularly
important since a reduction in mean arterial pressure alone may
not evoke a corresponding reduction in glomerular pressure in the
absence of reduced efferent arteriolar tone [26]. SNGFR in-
creased slightly (P = 0.1) by o-3 fatty acid administration, largely
as a consequence of an increase in QA. The latter was incident to
a net decrease in total renal vascular resistance (2.63 0.48 vs.
1.27 0.08 days X second X cm5 X loin). Although, the
ultrafiltration coefficient appeared to increase after w-3 fatty acid
supplementation this trend did not achieve statistical significance
(P = 0.08). Collectively, the hemodynamic effects observed after
(0-3 fatty acid administration are reminiscent of those observed
after angiotensin II blockade, suggesting a parallel mechanism of
action.
Study 2
w-3 fatty acid supplementation had a marked effect on angio-
tensin Il-stimulated phospholipid turnover in freshly isolated
glomeruli. Whereas sn-1,2-DAG peaked between 60 and 120
seconds in control glomeruli, no such increment was observed in
glomeruli obtained from rats fed fatty acid enriched diets (Fig.
1A). Accordingly, sn-1,2-DAG mass approximately doubled in
control glomeruli stimulated with angiotensin II, while little
increase was observed in glomeruli obtained from rats previously
maintained on diets enriched with w-3 fatty acids (Fig. 1B). The
fatty acid content of intact glomeruli (Fig. 2) was analogous to the
profile obtained in whole kidney cortex (Fig. 4). Thus, menhaden
oil increased the relative concentration of glomerular (0-3 fatty
acids while diminishing the content of the w-6 class of fatty acids.
Study 3
Glomerular injury was significantly lessened in nephrectomized
rats maintained on diets enriched with co-3 fatty acids. Specifically,
albuminuria was reduced by 50 to 75% at each study interval (Fig.
3A). Urinary albumin excretion averaged 45.5 9.7 mg/24 hr
three weeks after subtotal renal ablation as compared to 16.5 ±
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Fig. 2. Percent fatty acid content of intact glomeruli. Symbols are: (•)
control glomeruli; (LI) isolated glomeruli from rats maintained on diets
enriched with w-3 fatty acids. Abbreviations are: 16:0, palmitic acid; 18:0,
stearic acid; 18:0 (o-9), oleic acid; 18:2 (u-6), linoleic acid; 20:4 (w-6),
arachidonic acid; 20:5 (w-3), eicosapentaenoic acid; 22:5 (w-3), docosa-
pentaenoic acid; 22:6 (w-3), docosahexaenoic acid. < 0.05 vs. controls.
5.2 mg/24 hr in nephrectomized rats receiving diets enriched with
w-3 fatty acids. Albuminuria increased to 113.7 8.6 mg124 hr
nine weeks after subtotal nephrectomy as compared to 60.7 3.2
mg!24 hr in nephrectomized rats fed fatty acid enriched diets. As
a corollary glomerular morphometry revealed a marked attenua-
tion of sclerosis index in rats receiving w-3 fatty acid supplemen-
tation (0.83 0.2 vs. 0.20 0.1; Fig. 3B). Indeed, the sclerosis
index of treated rats was similar to two-kidney control rats.
Glomerular growth was also reduced in treated rats as manifested
by a reduction in mean glomerular area (7178 462 vs. 6223
499 m2) and volume (0.77 0.07 vs. 0.62 0.08 m3). Serum
cholesterol and creatinine were increased in rats with renal
ablation as compared to control rats or nephrectomized rats
maintained on a-3 fatty acids (Table 2). A significant decrease in
total serum protein and albumin was also evident in untreated rats
with renal ablation. Although w-3 fatty acids may directly modu-
late lipid metabolism, the metabolic changes detailed above may
also be consistent with attenuated renal injury and the attendant
decrease in glomerular proteinuria.
Several changes in fatty acid content of the remnant kidney
cortex were identified (Fig. 4). These included a 48% increase in
oleic acid (18:1, w-9) and a 15% decrease in the oleate progenitor,
stearic acid (18:0). Depletion of the w-6 fatty acids, arichidonate
(20:4, w-6) and linoleate (18:2, w-6) by 10% and 25%, respec-
tively, was also observed. These changes are consistent with
previous studies from our laboratory in this model [171.
The results of renal cortical fatty acid analysis in rats main-
tained on w-3 fatty acids were reflective of the diet administered
to the animals. The most striking changes occurred in the
polyunsaturated fatty acid fraction. In particular, eicosapenta-
enoic acid (20:5,w-3) concentration increased from 1.66 0.7% to
12.3 0.4% in rats fed diets enriched with co-3 fatty acids.
Docosahexaenoic acid (22:6, w-3) also increased significantly in
rats maintained on diets enriched with w-3 fatty acids (5.50
0.31% vs. 4.05 0.14% in treated and untreated nephrectomized
rats, respectively). A similar albeit statistically insignificant in-
crease in docosapentaenoic acid (22:5, e-3) was also observed in
rats fed w-3 fatty acids. Chronic administration of o-3 fatty acid
enriched diets restored the oleate and stearate concentrations to
normal in nephrectomized rats. However, a-3 fatty acid adminis-
tration did not restore the a-6 fatty acid content to control values.
Indeed, w-3 fatty acids resulted in a further decrease in w-6 fatty
acid content in the nephrectomized rat. The latter phenomenon
likely reflects a homeostatic attempt to maintain the overall
unsaturation index of the kidney constant following the incorpo-
ration of highly unsaturated fatty acids of the w-3 class [27, 281.
Renal prostaglandin excretion was also affected by the admin-
istration of diets enriched with w-3 fatty acids. Importantly,
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Fig. 3. Indices of renal inju7y. A. Twenty-four-
hour urinary albumin excretion (UAIbV) in
control rats (•), or rats with subtotal renal
ablation (SRA) maintained on standard chow
(0) or chow enriched with w-3 fatty acids (LI).
*p < 0.05 vs. control; tP < 0.05 vs. SRA. B.
Sclerosis index of rats with subtotal renal
w-3 FAs SRA Control ablation (SRA) versus control rats or SRA rats
maintained on chow enriched with w-3 fatty
acids. p < 0.05 vs. other groups.
Fig. 4. Percent fatty acid content of renal cortex. Symbols are: (LI) rats with
subtotal renal ablation maintained on diets enriched with a-3 fatty acid;
(g) rats with subtotal renal ablation on standard chow; (•) control rats.
Abbreviations are: 16:0, palmitic acid; 18:0, stearic acid; 18:0 (w-9), oleic
acid; 18:2 (w-6), linoleic acid; 20:4 (co-6), arachidonic acid; 20:5 (u-3),
eicosapentaenoic acid; 22:5 (w-3), docosapentaenoic acid; 22:6 (w-3),
docosahexaenoic acid. tP < 0.05 vs. other groups.
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Table 2. Laboratory data of control rats, rats subjected to subtotal
renal ablation (SRA) and SRA rats maintained on diets enriched with
a-3 fatty acids
Serum
chemistries Control SRA SRA + w-3 FAs
Chol mgldl 80.3 5.4 112.9 22.9k' 98.2 87ab
TG mgldl 78.7 4.4 61.2 20.0 50.5 5.3
BUN mg/dl 18.9 1.0 33.5 5.6 34.1 4.1u
Cr mgldl 0.39 0.0 0.92 0.T 0.75 03b
AIb glliter 3.19 0.5 1.95 0.2a 2.35 0.0-"
TSP g/liter 6.41 0.2 4.45 0.3a 5.08 0.1'
30
25
20
15
10
5
Cl)
-o0
>
cci
C
ci)0
ci)0
Abbreviations are: Chol, cholesterol; TG, triglycerides; BUN, blood
urea nitrogen; Cr, creatinine; Alb, albumin; TSP, total serum protein.
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urinary excretion of the potent renal vasoconstrictor TXA2 was
reduced at each study period in rats maintained on fatty acid
enriched diets compared to untreated rats (Fig. 5, left). Indeed,
w-3 fatty acid supplementation completely abrogated the expected
increase in renal TXB2 excretion. While PGE2 excretion in-
creased slightly in rats subjected to subtotal renal ablation, this
trend did not achieve statistical significance. A slight, albeit
statistically insignificant, attenuation of PGE2 excretion was also
observed in rats maintained on diets enriched with o-3 fatty acids
compared to untreated rats (Fig. SB). These findings suggests that
administration of w-3 fatty acid enriched diets favorably alters the
vasoconstrictor to vasodilator prostaglandin ratio in remnant
nephrons and provides a possible clue to the underlying mecha-
nism of arteriolar dilation following this dietary maneuver.
Discussion
As anticipated, glomerular hyperfiltration, glomerular hyper-
perfusion, and glomerular capillary hypertension were obtained in
rats subjected to subtotal renal ablation [8]. That such adaptive
changes in nephron function serve to potentiate progressive renal
injury has received extensive support and has advanced the
concept that selective lowering of glomerular hydraulic pressure is
an important therapeutic objective in the management of progres-
sive renal disease. Thus, an important finding in the present
investigation was the salutary effect of o-3 fatty acid administra-
tion on GC The beneficial effects of w-3 fatty acids on intraglo-
merular pressure appeared to derive from at least two factors.
First, dietary enrichment with w-3 fatty acids reduced mean
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arterial pressure which, in turn, would effectively diminish pres-
sure transmitted to the glomerular capillary network. And sec-
ondly, w-3 fatty acids resulted in a significant reduction in efferent
arteriolar resistance which would fundamentally dissipate glomer-
ular pressure. The latter effect is particularly meaningful, since a
HT
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Fig. 5. Twenty-four hour urina,'y excretion of
dienoic prostaglandin metabolites. A. TXB2
excretion in control rats (Lii) versus
nephrectomized rats maintained on standard
chow (•) or chow enriched with co-3 fatty acids(0). P < 0.05 versus other groups. B. PGE2
excretion in control rats (LI) versus
0 3 6 9 12 0 3 6 9 12 nephrectomized rats maintained on standard
Time, weeks Time, weeks chow
(•) or chow enriched with o-3 fattf acids
reduction in mean arterial pressure per se is not necessarily
accompanied by a fall in P0 [26]. Indeed, the decrease in afferent
arteriolar resistance observed in the present study would tend to
facilitate the transmission of systemic pressure to the glomerular
capillary bed and, hence, offset the expected decrease in glomer-
ular pressure incident to diminished mean arterial pressure. Thus,
antihypertensive agents which decrease efferent arteriolar resis-
tance confer a selective advantage in the management of elevated
glomerular pressure, particularly in the setting of subtotal renal
ablation [29]. An increase in QA was also observed after dietary
enrichment with w-3 fatty acids, most likely attributable to a
reduction of total renal arteriolar resistance induced by this
dietary maneuver. SNGFR was only marginally increased after
dietary enrichment with w-3 fatty acids, presumably because of the
offsetting effects of increased °A and KF coupled with decreased
GC Importantly, while other strategies have been noted to
diminish glomerular capillary pressure in remnant glomeruli, such
as protein restriction, administration of L-arginine; the collective
hemodynamic effects of a-3 fatty acids on the renal microcircu-
lation paralleled those obtained after sustained inhibition of
angiotensin II converting-enzyme [7], thus supporting the hypoth-
esis that w- 3 fatty acids act on the renal microcirculation via a
mutual pathway of inhibition.
Interference with the intrarenal synthesis of TXA2 or blockade
with a selective TXA7 receptor antagonist ameliorates angiotensin
II stimulated increases in renal vascular resistance [30], suggesting
that angiotensin II elicits renal arteriolar vasoconstriction via a
TXA2 dependent pathway. Importantly, in our investigation, w-3
fatty acid administration resulted in a marked decrease in the
renal excretion of TXB2 at each study period. Indeed, the renal
excretion of TXB2 at the time of micropuncture was 180% less in
treated versus untreated rats. This finding offers one plausible
explanation for the marked diminution in renal vascular tone after
w-3 fatty acid ingestion. Administration of w-3 fatty acids in
various clinical and experimental settings has commonly been
associated with reductions in the liberation of TXA2 [31—33].
Indirect evidence suggests that w-3 fatty acids modulate dienoic
prostaglandin synthesis by serving as a competitive substrate for
cyclooxygenase. The latter effect is believed to favor the synthesis
of the less potent trienoic thromboxane analog, TXA1. Moreover,
such a phenomenon is postulated to contribute to the antiplatelet
and vascular effects of w-3 fatty acids [34]. Since the antibody used
to characterize TXB2 excretion in the present study does not
differentiate between dienoic or trienoic thromboxane metabo-
lites, the assay employed will generally overestimate thromboxane
derived from TXA2. However, this shortcoming serves to
strengthen the conclusion that a reduction in TXA2 synthesis is
obtained in rats fed diets enriched with w-3 fatty acids. Whether
w-3 fatty acids modulate TXA2 synthesis through other pathways
of inhibition remains to be characterized. However, a preliminary
report from our laboratory demonstrated no change in the
transcript levels for TXA2 synthase following the administration
of w-3 fatty acids to nephrectomized rats [35]. This finding
suggests that w-3 fatty acids exert their actions on TXA2 synthesis
via post-transcriptional modification(s) of TXA2.
Interestingly, we did not observe a significant change in the
urinary excretion of PGE2 in remnant rats treated with w-3 fatty
acid supplementation. Since the antisera utilized in this study
exhibits 100% cross-reactivity with PGE3, it is possible that the
urinary excretion of PGE2 is substantially less than that measured
by our assay. In this regard, one report demonstrated a significant
decrement in urinary PGE2 in rats fed diets enriched with fish oil
[12], while other laboratories have shown little change in urinary
PGE2 excretion after dietary administration of w-3 fatty acids [11].
It is likely that utilization of PGE2 antisera with variable cross-
reactivity to PGE3 contributes to disparate results among different
laboratories. Indeed, the dissimilar results of previous studies
coupled with variable antisera cross-reactivity precludes precise
understanding of the biological significance of changes in mea-
sured PGE2. However, it is worthwhile noting that the biological
potency of PGE3 is believed to be similar to that of PGE2 [33].
This contrasts sharply with the arguments presented above for the
trienoic metabolites of thromboxane and suggests that, overall,
dietary administration of w-3 fatty acids results in a relative
increase in the vasodilator/vasoconstrictor prostaglandin ratio.
An equally plausible explanation for the actions of a-3 fatty
acids on the renal microcirculation of nephrectomized rats can be
inferred from studies demonstrating diminished binding of angio-
tensin II to adrenal zona glomerulosa and smooth muscle cells
following pretreatment with polyunsaturated fatty acids [36, 37].
Thus, a-3 fatty acids could exert an inhibitory effect on angioten-
sin II receptor coupled intracellular signaling events [37, 38]
including the production of lipid second messengers [39]. Lipid
second messengers are believed to contribute to the constriction
of rat renal microvessels [40, 41]. In a preliminary report, lo-3 fatty
acid administration resulted in a blunted renal vasoconstrictor
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response to angiotensin II in the renal vasculature of the rat [42].
Dietary fish oil supplementation in humans has also been associ-
ated with a reduced pressor response to exogenous angiotensin II
[43]. Accordingly, we examined angiotensin Il-stimulated phos-
pholipid turnover in the intact glomerulus following chronic
dietary administration of a-3 fatty acids. Chronic pretreatment of
normal rats with w-3 fatty acids resulted in a marked diminution
in the liberation of sn-1,2-DAG following administration of
angiotensin II. This finding suggests that chronic dietary admin-
istration of w-3 fatty acids inhibit angiotensin Il-stimulated mem-
brane lipid turnover in the intact glomerulus. Thus, it is possible
that altered angiotensin II stimulated intracellular release of lipid
second messengers contributes to arteriolar vasodilatation follow-
ing dietary enrichment with w-3 fatty acids. Whether similar
findings occur in glomeruli obtained from rats subjected to
subtotal renal ablation cannot answered by the present studies.
However, glomeruli obtained from remnant rats contain varying
degrees of mesangial expansion and glomerulosclerosis resulting
in inconsistent phospholipid turnover and, therefore, disparate
findings (unpublished observations).
An important additional finding in the present investigation was
the attenuation of renal injury incurred by dietary enrichment
with w-3 fatty acids. Both proteinuria and glomeruloscierosis were
lessened by dietary administration of w-3 fatty acids. Glomerular
growth, as manifested by glomerular area and volume were
correspondingly reduced after dietary supplementation with w-3
fatty acids. Importantly, a beneficial effect of w-3 fatty acid
enriched diets on glomerular structure and function has been
reported in three previous studies in the remnant model of renal
injury [9—11]. In contrast, one study in the remnant model of
experimental renal injury [12] has demonstrated a deleterious
effect of fish oil administration on renal structure and function.
The latter study differed from previous studies, and our own, by
the omission of essential fatty acid supplements and antioxidants
from the fatty acid enriched diets [10]. Importantly, omission of
antioxidants may allow highly unsaturated fatty acids to undergo
oxidation while in storage. Subsequent ingestion of oxidized lipids
may then result in direct tissue injury and contribute to early
mortality and loss of renal function. Although the mechanism
responsible for attenuating glomerular injury in remnant rats fed
diets enriched with w-3 fatty acids remains uncertain, we hypoth-
esize that the reduction in glomerular hydraulic pressure obtained
in the present study exerts a beneficial effect on progressive renal
injury [29, 44].
An additional factor which may have contributed to progressive
glomerular destruction in this study was the increase in circulating
cholesterol observed in rats with advancing renal disease [45].
Since dietary enrichment with w-3 fatty acids was associated with
a reduction in circulating cholesterol, it is possible that these
agents exerted a beneficial effect on progressive glomerular injury
through modulation of lipid metabolism. Such a lipid lowering
effect is well described following dietary enrichment with w-3 fatty
acids [2, 5]. However, w-3 fatty acids typically result in striking
decreases in circulating triglycerides, whereas the effects of these
compounds on serum cholesterol are generally minor. Therefore,
we suspect that the modest effects of o-3 fatty acids on serum
cholesterol in the present investigation were secondary to the
beneficial effects of o-3 fatty acids on glomerular proteinuria
rather than a metabolic effect per se induced by this dietary
maneuver. Regardless, the lipid lowering effect of o-3 fatty acids
in the setting of renal disease may subsequently elicit a favorable
effect on the course of progressive glomerular destruction.
Several changes in cortical fatty acids were observed in ne-
phrectomized rats with advancing renal disease. The most striking
alterations included a fall in linoleic, arachidonic, and stearic acid
concentration and a rise in oleic acid concentration. We have
recently described these changes in detail and have coupled these
events to increased endogenous turnover of arachidonic acid
metabolites in the remnant kidney [17]. w-3 fatty acid administra-
tion abrogated the changes in oleic and stearic acid content in
nephrectomized rats, a finding consistent with previous studies
from our laboratory demonstrating amelioration of these long
chain fatty acid changes incident to diminished arachidonic acid
turnover [17]. In contrast, the decrement in (0-6 fatty acid content
was exacerbated by w-3 fatty acid administration. Although, these
data appear to conflict with our earlier report [17], the interaction
of dietary (0-31(0-6 intake reflect metabolic selectivities which
maintain highly unsaturated fatty acid composition in tissue lipids
constant [27]. Such a phenomenon is also in accord with studies
examining the physical properties of cell membranes, such as
membrane fluidity [46, 47]. Importantly, this phenomenon may
contribute to the decline in TXB2 excretion observed in rats fed
w-3 fatty acids since the availability of precursor (arachidonic
acid) fatty acids would necessarily limit the synthesis of dienoic
prostaglandins. Thus, the fatty acid changes induced by w-3 fatty
acids in this setting likely represent a series of biochemical
adjustments to alterations in eicosanoid synthesis, membrane
physical properties, and renal injury per se.
In summary, dietary enrichment with w-3 fatty acids abrogated
glomerular capillary hypertension and lessened renal injury in the
remnant model of experimental renal disease. The mechanism(s)
responsible for the attenuation of intraglomerular hypertension in
rats treated with o-3 fatty acids included a salutary effect on mean
arterial pressure and a decrease in efferent arteriolar resistance.
w-3 fatty acids may exert these hemodynamic effects by reducing
angiotensin Il-dependent signaling events, such as phospholipid
hydrolysis or by limiting the synthesis of the potent renal vaso-
constrictor, TXA2. The latter findings coupled with the effects of
these agents on glomerular injury are reminiscent of those
observed following the administration of agents which block
angiotensin II converting-enzyme, and thus support the notion
that these compounds act through a parallel pathway. Regardless,
these studies furnish a physiological rationale which could poten-
tially be applied to the treatment of progressive renal disease.
Indeed, the favorable effects of w-3 fatty acids on renal hemody-
namics reported in this study may have surreptitiously contributed
to the salutary outcome in recent clinical trials in which fish oil
was administered to patients with IgA nephropathy and recipients
of renal allografts [48, 49].
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